Skip to main content
Top
Published in: BMC Immunology 1/2006

Open Access 01-12-2006 | Research article

Similarities in the immunoglobulin response and VH gene usage in rhesus monkeys and humans exposed to porcine hepatocytes

Authors: Joanne L Zahorsky-Reeves, Clare R Gregory, Donald V Cramer, Insiyyah Y Patanwala, Andrew E Kyles, Dominic C Borie, Mary K Kearns-Jonker

Published in: BMC Immunology | Issue 1/2006

Login to get access

Abstract

Background

The use of porcine cells and organs as a source of xenografts for human patients would vastly increase the donor pool; however, both humans and Old World primates vigorously reject pig tissues due to xenoantibodies that react with the polysaccharide galactose α (1,3) galactose (αGal) present on the surface of many porcine cells. We previously examined the xenoantibody response in patients exposed to porcine hepatocytes via treatment(s) with bioartficial liver devices (BALs), composed of porcine cells in a support matrix. We determined that xenoantibodies in BAL-treated patients are predominantly directed at porcine αGal carbohydrate epitopes, and are encoded by a small number of germline heavy chain variable region (VH) immunoglobulin genes. The studies described in this manuscript were designed to identify whether the xenoantibody responses and the IgVH genes encoding antibodies to porcine hepatocytes in non-human primates used as preclinical models are similar to those in humans. Adult non-immunosuppressed rhesus monkeys (Macaca mulatta) were injected intra-portally with porcine hepatocytes or heterotopically transplanted with a porcine liver lobe. Peripheral blood leukocytes and serum were obtained prior to and at multiple time points after exposure, and the immune response was characterized, using ELISA to evaluate the levels and specificities of circulating xenoantibodies, and the production of cDNA libraries to determine the genes used by B cells to encode those antibodies.

Results

Xenoantibodies produced following exposure to isolated hepatocytes and solid organ liver grafts were predominantly encoded by genes in the VH3 family, with a minor contribution from the VH4 family. Immunoglobulin heavy-chain gene (VH) cDNA library screening and gene sequencing of IgM libraries identified the genes as most closely-related to the IGHV3-11 and IGHV4-59 germline progenitors. One of the genes most similar to IGHV3-11, VH3-11cyno, has not been previously identified, and encodes xenoantibodies at later time points post-transplant. Sequencing of IgG clones revealed increased usage of the monkey germline progenitor most similar to human IGHV3-11 and the onset of mutations.

Conclusion

The small number of IGVH genes encoding xenoantibodies to porcine hepatocytes in non-human primates and humans is highly conserved. Rhesus monkeys are an appropriate preclinical model for testing novel reagents such as those developed using structure-based drug design to target and deplete antibodies to porcine xenografts.
Appendix
Available only for authorised users
Literature
1.
go back to reference Samstein B, Platt JL: Physiologic and immunologic hurdles to xenotransplantation. J Am Soc Nephrol. 2001, 12: 182-193.PubMed Samstein B, Platt JL: Physiologic and immunologic hurdles to xenotransplantation. J Am Soc Nephrol. 2001, 12: 182-193.PubMed
2.
go back to reference Cooper DK, Good AH, Koren E: Identification of alpha-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: relevance to discordant xenografting in man. Transpl Immunol. 1993, 1: 198-205. 10.1016/0966-3274(93)90047-C.CrossRefPubMed Cooper DK, Good AH, Koren E: Identification of alpha-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: relevance to discordant xenografting in man. Transpl Immunol. 1993, 1: 198-205. 10.1016/0966-3274(93)90047-C.CrossRefPubMed
3.
go back to reference Galili U, Anaraki F, Thall A, Hill-Black C, Radic M: One percent of human circulating B lymphocytes are capable of producing the natural anti-Gal antibody. Blood. 1993, 82: 2485-93.PubMed Galili U, Anaraki F, Thall A, Hill-Black C, Radic M: One percent of human circulating B lymphocytes are capable of producing the natural anti-Gal antibody. Blood. 1993, 82: 2485-93.PubMed
4.
go back to reference Lin SS, Hanaway MJ, Gonzalez-Stawinski GV, Lau CL, Parker W, Davis RD, Byrne GW, Diamond LE, Logan JS, Platt JL: The role of anti-Gal alpha1-3Gal antibodies in acute vascular rejection and accommodation of xenografts. Transplantation. 2000, 70: 1667-74. 10.1097/00007890-200012270-00002.CrossRefPubMed Lin SS, Hanaway MJ, Gonzalez-Stawinski GV, Lau CL, Parker W, Davis RD, Byrne GW, Diamond LE, Logan JS, Platt JL: The role of anti-Gal alpha1-3Gal antibodies in acute vascular rejection and accommodation of xenografts. Transplantation. 2000, 70: 1667-74. 10.1097/00007890-200012270-00002.CrossRefPubMed
5.
go back to reference Stinson EB, Griepp RB, Oyer PE, Shumway NE: Long-term experience with porcine aortic valve xenografts. J Thor Cardiovasc Surgery. 1977, 73: 54-63. Stinson EB, Griepp RB, Oyer PE, Shumway NE: Long-term experience with porcine aortic valve xenografts. J Thor Cardiovasc Surgery. 1977, 73: 54-63.
6.
go back to reference Groth CG, Tibell A, Wennberg L, Korsgren O: Xenoislet transplantation: experimental and clinical aspects. J Mol Med. 1999, 77: 153-154. 10.1007/s001090050325.CrossRefPubMed Groth CG, Tibell A, Wennberg L, Korsgren O: Xenoislet transplantation: experimental and clinical aspects. J Mol Med. 1999, 77: 153-154. 10.1007/s001090050325.CrossRefPubMed
7.
go back to reference Horslen SP, Hammel JM, Fristoe LW, Kangas JA, Collier DS, Sudan DL, Langnas AN, Dixon RS, Prentice ED, Shaw BW, Fox IJ: Extracorporeal liver perfusion using human and pig livers for acute liver failure. Transplantation. 2000, 70: 1472-78. 10.1097/00007890-200011270-00014.CrossRefPubMed Horslen SP, Hammel JM, Fristoe LW, Kangas JA, Collier DS, Sudan DL, Langnas AN, Dixon RS, Prentice ED, Shaw BW, Fox IJ: Extracorporeal liver perfusion using human and pig livers for acute liver failure. Transplantation. 2000, 70: 1472-78. 10.1097/00007890-200011270-00014.CrossRefPubMed
8.
go back to reference Pascher A, Sauer IM, Hammer C, Gerlach JC, Nauhaus P: Extracorporeal liver perfusion as hepatic assist in acute liver failure: a review of world experience. Xenotransplantation. 2002, 9: 309-24. 10.1034/j.1399-3089.2002.01076.x.CrossRefPubMed Pascher A, Sauer IM, Hammer C, Gerlach JC, Nauhaus P: Extracorporeal liver perfusion as hepatic assist in acute liver failure: a review of world experience. Xenotransplantation. 2002, 9: 309-24. 10.1034/j.1399-3089.2002.01076.x.CrossRefPubMed
9.
go back to reference Naruse K, Sakai Y, Guo L, Natori T, Shindoh J, Karasawa Y, Iida Y, Kojima K, Michishita K, Makuuchi M: Development of a new extracorporeal whole-liver perfusion system. J Artif Organs. 2003, 6: 211-17. 10.1007/s10047-003-0225-9.CrossRefPubMed Naruse K, Sakai Y, Guo L, Natori T, Shindoh J, Karasawa Y, Iida Y, Kojima K, Michishita K, Makuuchi M: Development of a new extracorporeal whole-liver perfusion system. J Artif Organs. 2003, 6: 211-17. 10.1007/s10047-003-0225-9.CrossRefPubMed
10.
go back to reference Ueda Y, Iwata H, Paek HJ, Ko IK, Shimooka Y, Katsura N, Ikai I, Yamaoka Y, Ikada Y: Bioartificial liver with whole blood perfusion. ASAIO Journal. 2003, 49: 401-406.PubMed Ueda Y, Iwata H, Paek HJ, Ko IK, Shimooka Y, Katsura N, Ikai I, Yamaoka Y, Ikada Y: Bioartificial liver with whole blood perfusion. ASAIO Journal. 2003, 49: 401-406.PubMed
11.
go back to reference Hui T, Rozga J, Demetriou AA: Bioartificial liver support. J Hepato Pancreat. 2001, 8: 1-15. 10.1007/s005340170045.CrossRef Hui T, Rozga J, Demetriou AA: Bioartificial liver support. J Hepato Pancreat. 2001, 8: 1-15. 10.1007/s005340170045.CrossRef
12.
go back to reference Mazariegos GV, Kramer DJ, Lopez RC, Shakil AO, Rosenbloom AJ, DeVera M, Giraldo M, Grogan TA, Zhu Y, Fulmer ML, Amiot BP, Patzer JF: Safety observations in phase I clinical evaluation of the Excorp medical bioartificial liver support system after the first four patients. ASAIO Journal. 2001, 47: 471-75. 10.1097/00002480-200109000-00015.CrossRefPubMed Mazariegos GV, Kramer DJ, Lopez RC, Shakil AO, Rosenbloom AJ, DeVera M, Giraldo M, Grogan TA, Zhu Y, Fulmer ML, Amiot BP, Patzer JF: Safety observations in phase I clinical evaluation of the Excorp medical bioartificial liver support system after the first four patients. ASAIO Journal. 2001, 47: 471-75. 10.1097/00002480-200109000-00015.CrossRefPubMed
13.
go back to reference Mazariegos GV, Patzer JF, Lopez RC, Giraldo M, Devera ME, Grogan TA, Zhu Y, Fulmer ML, Amiot BP, Kramer DJ: First clinical use of a novel bioartificial liver support system (BLSS). Am J Transplant. 2002, 2: 260-66. 10.1034/j.1600-6143.2002.20311.x.CrossRefPubMed Mazariegos GV, Patzer JF, Lopez RC, Giraldo M, Devera ME, Grogan TA, Zhu Y, Fulmer ML, Amiot BP, Kramer DJ: First clinical use of a novel bioartificial liver support system (BLSS). Am J Transplant. 2002, 2: 260-66. 10.1034/j.1600-6143.2002.20311.x.CrossRefPubMed
14.
go back to reference Sauer IM, Kardassis D, Zeillinger K, Pascher A, Gruenwald A, Pless G, Irgang M, Kraemer M, Puhl G, Frank J, Muller AR, Steinmuller T, Denner J, Neuhaus P, Gerlach JC: Clinical extracorporeal hybrid support – phase I study with primary porcine liver cells. Xenotransplantation. 2003, 10: 460-69. 10.1034/j.1399-3089.2003.00062.x.CrossRefPubMed Sauer IM, Kardassis D, Zeillinger K, Pascher A, Gruenwald A, Pless G, Irgang M, Kraemer M, Puhl G, Frank J, Muller AR, Steinmuller T, Denner J, Neuhaus P, Gerlach JC: Clinical extracorporeal hybrid support – phase I study with primary porcine liver cells. Xenotransplantation. 2003, 10: 460-69. 10.1034/j.1399-3089.2003.00062.x.CrossRefPubMed
15.
go back to reference Court FG, Wemyss-Holden SA, Dennison AR, Maddern GJ: Bioartificial liver support devices: historical perspectives. ANZ J Surgery. 2003, 73: 739-48. 10.1046/j.1445-2197.2003.02741.x.CrossRef Court FG, Wemyss-Holden SA, Dennison AR, Maddern GJ: Bioartificial liver support devices: historical perspectives. ANZ J Surgery. 2003, 73: 739-48. 10.1046/j.1445-2197.2003.02741.x.CrossRef
16.
go back to reference Baquerizo A, Mhoyan A, Kearns-Jonker M, Arnaout WS, Shackleton C, Busuttil RW, Demetriou AA, Cramer DV: Characterization of human xenoreactive antibodies in liver failure patients exposed to pig hepatocytes after bioartificial liver treatment: an ex vivo model of pig to human xenotransplantation. Transplantation. 1999, 67: 5-18. 10.1097/00007890-199901150-00003.CrossRefPubMed Baquerizo A, Mhoyan A, Kearns-Jonker M, Arnaout WS, Shackleton C, Busuttil RW, Demetriou AA, Cramer DV: Characterization of human xenoreactive antibodies in liver failure patients exposed to pig hepatocytes after bioartificial liver treatment: an ex vivo model of pig to human xenotransplantation. Transplantation. 1999, 67: 5-18. 10.1097/00007890-199901150-00003.CrossRefPubMed
17.
go back to reference Kearns-Jonker M, Swensson J, Ghiuzeli C, Chu W, Osame Y, Starnes V, Cramer DV: The human antibody response to porcine xenoantigens is encoded by IGHV3-11 and IGVH3-74 IGVH germline progenitors. J Immunol. 1999, 163: 4399-412.PubMed Kearns-Jonker M, Swensson J, Ghiuzeli C, Chu W, Osame Y, Starnes V, Cramer DV: The human antibody response to porcine xenoantigens is encoded by IGHV3-11 and IGVH3-74 IGVH germline progenitors. J Immunol. 1999, 163: 4399-412.PubMed
18.
go back to reference Dehoux JP, de la Parra B, Latinne D, Bazin H, Gianello P: Characterization of baboon anti-porcine IgG antibodies during acute vascular rejection of porcine kidney xenograft. Xenotransplantation. 2002, 9: 338-349. 10.1034/j.1399-3089.2002.01090.x.CrossRefPubMed Dehoux JP, de la Parra B, Latinne D, Bazin H, Gianello P: Characterization of baboon anti-porcine IgG antibodies during acute vascular rejection of porcine kidney xenograft. Xenotransplantation. 2002, 9: 338-349. 10.1034/j.1399-3089.2002.01090.x.CrossRefPubMed
19.
go back to reference Wang L, Radic MZ, Galili U: Human anti-Gal heavy chain genes. Preferential use of VH3 and the presence of somatic mutations. J Immunology. 1995, 155: 1276-1285. Wang L, Radic MZ, Galili U: Human anti-Gal heavy chain genes. Preferential use of VH3 and the presence of somatic mutations. J Immunology. 1995, 155: 1276-1285.
20.
go back to reference Tapinos NI, Polihronis M, Thyphronitis G, Moutsopoulos HM: Characterization of the cysteine-rich secretory protein 3 gene as an early-transcribed gene with a putative role in the pathophysiology of Sjogren's syndrome. Arthritis Rheum. 2002, 46: 215-222. 10.1002/1529-0131(200201)46:1<215::AID-ART10024>3.0.CO;2-M.CrossRefPubMed Tapinos NI, Polihronis M, Thyphronitis G, Moutsopoulos HM: Characterization of the cysteine-rich secretory protein 3 gene as an early-transcribed gene with a putative role in the pathophysiology of Sjogren's syndrome. Arthritis Rheum. 2002, 46: 215-222. 10.1002/1529-0131(200201)46:1<215::AID-ART10024>3.0.CO;2-M.CrossRefPubMed
21.
go back to reference Segel GB, Woodlock TJ, Xu J, Li L, Felgar RE, Ryan DH, Lichtman MA, Wang N: Early gene activation in chronic leukemic B lymphocytes induced toward a plasma cell phenotype. Blood Cells Mol Dis. 2003, 30: 27-287. 10.1016/S1079-9796(03)00035-4.CrossRef Segel GB, Woodlock TJ, Xu J, Li L, Felgar RE, Ryan DH, Lichtman MA, Wang N: Early gene activation in chronic leukemic B lymphocytes induced toward a plasma cell phenotype. Blood Cells Mol Dis. 2003, 30: 27-287. 10.1016/S1079-9796(03)00035-4.CrossRef
22.
go back to reference Blouin A, Bolender RP, Weibel ER: Distribution of organelles and membranes between hepatocytes and nonhepatocytes in the rat liver parenchyma: a stereological study. J Cell Biology. 1977, 72: 441-455. 10.1083/jcb.72.2.441.CrossRef Blouin A, Bolender RP, Weibel ER: Distribution of organelles and membranes between hepatocytes and nonhepatocytes in the rat liver parenchyma: a stereological study. J Cell Biology. 1977, 72: 441-455. 10.1083/jcb.72.2.441.CrossRef
23.
go back to reference Sandrin MS, McKenzie IF: Gal alpha (1,3) Gal, the major xenoantigen(s) recognized in pigs by human natural antibodies. Immunol Rev. 1994, 141: 169-190.CrossRefPubMed Sandrin MS, McKenzie IF: Gal alpha (1,3) Gal, the major xenoantigen(s) recognized in pigs by human natural antibodies. Immunol Rev. 1994, 141: 169-190.CrossRefPubMed
24.
go back to reference Tanemura M, Galili U: Differential expression of a-Gal on pig and mouse organs. Transplant Proceed. 2000, 32: 843-10.1016/S0041-1345(00)01002-2.CrossRef Tanemura M, Galili U: Differential expression of a-Gal on pig and mouse organs. Transplant Proceed. 2000, 32: 843-10.1016/S0041-1345(00)01002-2.CrossRef
25.
go back to reference Kearns-Jonker M, Bolger MB, Mencel R, Barteneva N, Starnes VA, Cramer DV: Analysis of contact residues and the binding site configuration of induced xenoantibodies that bind to the gal carbohydrate [abstract]. American Journal of Transplantation. 2002, 3: 178- Kearns-Jonker M, Bolger MB, Mencel R, Barteneva N, Starnes VA, Cramer DV: Analysis of contact residues and the binding site configuration of induced xenoantibodies that bind to the gal carbohydrate [abstract]. American Journal of Transplantation. 2002, 3: 178-
26.
go back to reference Helmuth EF, Letvin NL, Margolin DH: Germline repertoire of the immunoglobulin V(H)3 family in rhesus monkeys. Immunogenetics. 2000, 51: 519-527. 10.1007/s002510000170.CrossRefPubMed Helmuth EF, Letvin NL, Margolin DH: Germline repertoire of the immunoglobulin V(H)3 family in rhesus monkeys. Immunogenetics. 2000, 51: 519-527. 10.1007/s002510000170.CrossRefPubMed
27.
go back to reference Andris JS, Miller AB, Abraham S, Cunningham S, Roubinet F, Blancher A, Capra JD: Variable region gene segment utilization in rhesus monkey hybridomas producing human red blood cell-specific antibodies: predominance of the VH4 family but not VH4-21 (V4-34). Molecular Immunology. 1997, 34: 237-253. 10.1016/S0161-5890(97)00021-7.CrossRefPubMed Andris JS, Miller AB, Abraham S, Cunningham S, Roubinet F, Blancher A, Capra JD: Variable region gene segment utilization in rhesus monkey hybridomas producing human red blood cell-specific antibodies: predominance of the VH4 family but not VH4-21 (V4-34). Molecular Immunology. 1997, 34: 237-253. 10.1016/S0161-5890(97)00021-7.CrossRefPubMed
28.
go back to reference Teranishi K, Gollackner B, Buhler L, Knosalla C, Correa L, Down JD, White-Scharf ME, Sachs DH, Awwad M, Cooper DK: Depletion of anti-gal antibodies by intravenous therapy with bovine serum albumin conjugated to gal oligosaccharides. Transplantation. 2002, 73: 129-139. 10.1097/00007890-200201150-00024.CrossRefPubMed Teranishi K, Gollackner B, Buhler L, Knosalla C, Correa L, Down JD, White-Scharf ME, Sachs DH, Awwad M, Cooper DK: Depletion of anti-gal antibodies by intravenous therapy with bovine serum albumin conjugated to gal oligosaccharides. Transplantation. 2002, 73: 129-139. 10.1097/00007890-200201150-00024.CrossRefPubMed
29.
go back to reference Katopodis AG, Warner RG, Duthaler RO, Streiff MB, Bruelisauer A, Kretz O, Dorobek B, Persohn E, Andres H, Schweitzer A, Thoma G, Kinzy W, Quesniaux VF, Cozzi E, Davies HF, Manez R, White D: Removal of anti-Galα1,3Gal xenoantibodies with an injectable polymer. J Clinical Invest. 2002, 110: 1869-1877. 10.1172/JCI200216526.CrossRef Katopodis AG, Warner RG, Duthaler RO, Streiff MB, Bruelisauer A, Kretz O, Dorobek B, Persohn E, Andres H, Schweitzer A, Thoma G, Kinzy W, Quesniaux VF, Cozzi E, Davies HF, Manez R, White D: Removal of anti-Galα1,3Gal xenoantibodies with an injectable polymer. J Clinical Invest. 2002, 110: 1869-1877. 10.1172/JCI200216526.CrossRef
30.
go back to reference Karoor S, Molina J, Buchmann CR: Immunoaffinity removal of xenoreactive antibodies using modified dialysis or microfiltration membranes. Biotechnol Bioeng. 2003, 81: 134-148. 10.1002/bit.10555.CrossRefPubMed Karoor S, Molina J, Buchmann CR: Immunoaffinity removal of xenoreactive antibodies using modified dialysis or microfiltration membranes. Biotechnol Bioeng. 2003, 81: 134-148. 10.1002/bit.10555.CrossRefPubMed
31.
go back to reference Tanemura M, Ogawa H, Yin DP, Chen ZC, DiSesa VJ, Galili U: Elimination of anti-Gal B cells by alpha-Gal ricin1. Transplantation. 2002, 73: 1859-1868. 10.1097/00007890-200206270-00002.CrossRefPubMed Tanemura M, Ogawa H, Yin DP, Chen ZC, DiSesa VJ, Galili U: Elimination of anti-Gal B cells by alpha-Gal ricin1. Transplantation. 2002, 73: 1859-1868. 10.1097/00007890-200206270-00002.CrossRefPubMed
32.
go back to reference McMorrow IM, Buhler L, Treter S, Neethling FA, Alwayn IP, Comrack CA, Kitamura H, Awwad M, DerSimonian H, Cooper DK, Sachs DH, LeGuern C: Modulation of the in vivo primate anti-Gal response through administration of anti-idiotypic antibodies. Xenotransplantation. 2002, 9: 10-114. 10.1034/j.1399-3089.2002.1o028.x.CrossRef McMorrow IM, Buhler L, Treter S, Neethling FA, Alwayn IP, Comrack CA, Kitamura H, Awwad M, DerSimonian H, Cooper DK, Sachs DH, LeGuern C: Modulation of the in vivo primate anti-Gal response through administration of anti-idiotypic antibodies. Xenotransplantation. 2002, 9: 10-114. 10.1034/j.1399-3089.2002.1o028.x.CrossRef
33.
go back to reference Lindeborg E, Kumagai-Braesch M, Tibell A, Moller E: Continued production of xenoimmune antibodies 6–8 years after clinical transplantation of fetal pig islet-like cell-clusters. Xenotransplantation. 2001, 8: 273-283. 10.1034/j.1399-3089.2001.00124.x.CrossRefPubMed Lindeborg E, Kumagai-Braesch M, Tibell A, Moller E: Continued production of xenoimmune antibodies 6–8 years after clinical transplantation of fetal pig islet-like cell-clusters. Xenotransplantation. 2001, 8: 273-283. 10.1034/j.1399-3089.2001.00124.x.CrossRefPubMed
34.
go back to reference Tinguely C, Schaller M, Carrel T, Nydegger UE: Spectrotype analysis and clonal characteristics of human anti-Gal alpha103Gal antibodies. Xenotransplantation. 2002, 9: 252-259. 10.1034/j.1399-3089.2002.00148.x.CrossRefPubMed Tinguely C, Schaller M, Carrel T, Nydegger UE: Spectrotype analysis and clonal characteristics of human anti-Gal alpha103Gal antibodies. Xenotransplantation. 2002, 9: 252-259. 10.1034/j.1399-3089.2002.00148.x.CrossRefPubMed
35.
go back to reference Wu GD, Gochi E, Jin Y-S, Swensson J, Starnes VA, Cramer DV: Maturation of xenoantibody gene expression during the humoral immune response of rats to hamster xenografts. Xenotransplantation. 2001, 8: 291-302. 10.1034/j.1399-3089.2001.00136.x.CrossRefPubMed Wu GD, Gochi E, Jin Y-S, Swensson J, Starnes VA, Cramer DV: Maturation of xenoantibody gene expression during the humoral immune response of rats to hamster xenografts. Xenotransplantation. 2001, 8: 291-302. 10.1034/j.1399-3089.2001.00136.x.CrossRefPubMed
36.
go back to reference Nozawa S, Xing PX, Wu GD, Gochi E, Kearns-Jonker M, Swensson J, Starnes VA, Sandrin MS, McKenzie IF, Cramer DV: Characteristics of immunoglobulin gene usage of the xenoantibody binding to gal-alpha(1,3)gal target antigens in the gal knockout mouse. Transplantation. 2001, 72: 147-155. 10.1097/00007890-200107150-00028.CrossRefPubMed Nozawa S, Xing PX, Wu GD, Gochi E, Kearns-Jonker M, Swensson J, Starnes VA, Sandrin MS, McKenzie IF, Cramer DV: Characteristics of immunoglobulin gene usage of the xenoantibody binding to gal-alpha(1,3)gal target antigens in the gal knockout mouse. Transplantation. 2001, 72: 147-155. 10.1097/00007890-200107150-00028.CrossRefPubMed
37.
go back to reference Kearns-Jonker M, Fraiman M, Chu W, Gochi E, Michel J, Wu GD, Cramer DV: Xenoantibodies to pig endothelium are expressed in germline configuration and share a conserved immunoglobulin VH gene structure with antibodies to common infectious agents. Transplantation. 1998, 65: 1515-1519. 10.1097/00007890-199806150-00023.CrossRefPubMed Kearns-Jonker M, Fraiman M, Chu W, Gochi E, Michel J, Wu GD, Cramer DV: Xenoantibodies to pig endothelium are expressed in germline configuration and share a conserved immunoglobulin VH gene structure with antibodies to common infectious agents. Transplantation. 1998, 65: 1515-1519. 10.1097/00007890-199806150-00023.CrossRefPubMed
38.
go back to reference Edwards BM, Barash SC, Main SH, Choi GH, Minter R, Ullrich S, Williams E, Du Fou L, Wilton J, Albert VR, Ruben SM, Vaughan TJ: The remarkable flexibility of the human antibody repertoire; isolation of over one thousand different antibodies to a single protein. J Molecular Biology. 2003, 334: 103-118. 10.1016/j.jmb.2003.09.054.CrossRef Edwards BM, Barash SC, Main SH, Choi GH, Minter R, Ullrich S, Williams E, Du Fou L, Wilton J, Albert VR, Ruben SM, Vaughan TJ: The remarkable flexibility of the human antibody repertoire; isolation of over one thousand different antibodies to a single protein. J Molecular Biology. 2003, 334: 103-118. 10.1016/j.jmb.2003.09.054.CrossRef
39.
go back to reference Barrios Y, Jirholt P, Ohlin M: Length of the antibody heavy chain complementarity determining region 3 as a specificity-determining factor. J Molecular Recognition. 2004, 17: 332-338. 10.1002/jmr.679.CrossRef Barrios Y, Jirholt P, Ohlin M: Length of the antibody heavy chain complementarity determining region 3 as a specificity-determining factor. J Molecular Recognition. 2004, 17: 332-338. 10.1002/jmr.679.CrossRef
40.
go back to reference Pan J, Naik S, Santangini H, Trenkler D, Jaurugui HO: Flow cytometric characterization of isolated porcine hepatocyte suspensions for liver support. Artificial Organs. 1996, 20: 1173-1180.CrossRefPubMed Pan J, Naik S, Santangini H, Trenkler D, Jaurugui HO: Flow cytometric characterization of isolated porcine hepatocyte suspensions for liver support. Artificial Organs. 1996, 20: 1173-1180.CrossRefPubMed
41.
go back to reference Buhler L, Deng S, O'Neil J, Kitamura A, Koulmanda M, Baldi A, Rahier J, Alwayn IP, Appel JZ, Awwad M, Sachs DH, Weir G, Squifflet JP, Cooper DK, Morel P: Adult porcine islet transplantation in baboons treated with conventional immunosuppression or a non-myeloablative regimen and CD154 blockade. Xenotransplantation. 2002, 9: 3-13. 10.1034/j.1399-3089.2002.1o044.x.CrossRefPubMed Buhler L, Deng S, O'Neil J, Kitamura A, Koulmanda M, Baldi A, Rahier J, Alwayn IP, Appel JZ, Awwad M, Sachs DH, Weir G, Squifflet JP, Cooper DK, Morel P: Adult porcine islet transplantation in baboons treated with conventional immunosuppression or a non-myeloablative regimen and CD154 blockade. Xenotransplantation. 2002, 9: 3-13. 10.1034/j.1399-3089.2002.1o044.x.CrossRefPubMed
42.
go back to reference Fujioka H, Cramer DV, Yasunaga C, Tuso PJ, Wu GD, Middleton Y, Moscioni AD, Rozga J, Demetriou AA, Makowka L: Differential patterns of reaction of human natural antibodies to pig hepatocytes and vascular endothelium. Liver Transpl Surgery. 1995, 1: 85-93. 10.1002/lt.500010203.CrossRef Fujioka H, Cramer DV, Yasunaga C, Tuso PJ, Wu GD, Middleton Y, Moscioni AD, Rozga J, Demetriou AA, Makowka L: Differential patterns of reaction of human natural antibodies to pig hepatocytes and vascular endothelium. Liver Transpl Surgery. 1995, 1: 85-93. 10.1002/lt.500010203.CrossRef
43.
go back to reference Shearer MH, Dark RD, Chodosh J, Kennedy RC: Comparison and characterization of immunoglobulin G subclasses among primate species. Clin Diag Lab Immunol. 1999, 6: 953-958. Shearer MH, Dark RD, Chodosh J, Kennedy RC: Comparison and characterization of immunoglobulin G subclasses among primate species. Clin Diag Lab Immunol. 1999, 6: 953-958.
44.
go back to reference Calvas P, Apoil P-A, Fortenfant F, Roubinet F, Andris J, Capra D, Blancher A: Characterization of the three immunoglobulin G subclasses of macaques. Scand J Immunol. 1999, 49: 595-610. 10.1046/j.1365-3083.1999.00540.x.CrossRefPubMed Calvas P, Apoil P-A, Fortenfant F, Roubinet F, Andris J, Capra D, Blancher A: Characterization of the three immunoglobulin G subclasses of macaques. Scand J Immunol. 1999, 49: 595-610. 10.1046/j.1365-3083.1999.00540.x.CrossRefPubMed
45.
go back to reference Scinicariello F, Engleman CN, Jayashankar L, McClure HM, Attanasio R: Rhesus macaque antibody molecules: sequences and heterogeneity of alpha and gamma constant regions. Immunology. 2004, 111: 66-74. 10.1111/j.1365-2567.2004.01767.x.PubMedCentralCrossRefPubMed Scinicariello F, Engleman CN, Jayashankar L, McClure HM, Attanasio R: Rhesus macaque antibody molecules: sequences and heterogeneity of alpha and gamma constant regions. Immunology. 2004, 111: 66-74. 10.1111/j.1365-2567.2004.01767.x.PubMedCentralCrossRefPubMed
46.
go back to reference Margolin DH, Reimann KA, Sodroski J, Karlsson GB, Tenner-Racz K, Racz P, Letvin NL: Immunoglobulin VH usage during primary infection of rhesus monkeys with chimeric simian-human immunodeficiency viruses. J Virol. 1997, 71: 8582-8591.PubMedCentralPubMed Margolin DH, Reimann KA, Sodroski J, Karlsson GB, Tenner-Racz K, Racz P, Letvin NL: Immunoglobulin VH usage during primary infection of rhesus monkeys with chimeric simian-human immunodeficiency viruses. J Virol. 1997, 71: 8582-8591.PubMedCentralPubMed
47.
go back to reference Meek K, Eversole T, Capra JD: Conservation of the most Jh proximal IgVH gene segment (VhVI) throughout primate evolution. J Immunol. 1991, 146: 2434-2438.PubMed Meek K, Eversole T, Capra JD: Conservation of the most Jh proximal IgVH gene segment (VhVI) throughout primate evolution. J Immunol. 1991, 146: 2434-2438.PubMed
48.
go back to reference Newman R, Alberts J, Carner ADK, Heard C, Norton F, Raab R, Reff M, Shuey S, Hanna N: "Primatization" of recombinant antibodies for immunotherapy of human diseases: a macaque/human chimeric antibody against human CD4. BioTechnology. 1992, 10: 1455-1460. 10.1038/nbt1192-1455.CrossRefPubMed Newman R, Alberts J, Carner ADK, Heard C, Norton F, Raab R, Reff M, Shuey S, Hanna N: "Primatization" of recombinant antibodies for immunotherapy of human diseases: a macaque/human chimeric antibody against human CD4. BioTechnology. 1992, 10: 1455-1460. 10.1038/nbt1192-1455.CrossRefPubMed
Metadata
Title
Similarities in the immunoglobulin response and VH gene usage in rhesus monkeys and humans exposed to porcine hepatocytes
Authors
Joanne L Zahorsky-Reeves
Clare R Gregory
Donald V Cramer
Insiyyah Y Patanwala
Andrew E Kyles
Dominic C Borie
Mary K Kearns-Jonker
Publication date
01-12-2006
Publisher
BioMed Central
Published in
BMC Immunology / Issue 1/2006
Electronic ISSN: 1471-2172
DOI
https://doi.org/10.1186/1471-2172-7-3

Other articles of this Issue 1/2006

BMC Immunology 1/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine